PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance

Soto Romuald Kiando, Nathan R Tucker, Luis-Jaime Castro-Vega, Alexander Katz, Valentina D'Escamard, Cyrielle Tréard, Daniel Fraher, Juliette Albuisson, Daniella Kadian-Dodov, Zi Ye, Erin Austin, Min-Lee Yang, Kristina Hunker, Cristina Barlassina, Daniele Cusi, Pilar Galan, Jean-Philippe Empana, Xavier Jouven, Anne-Paule Gimenez-Roqueplo, Patrick Bruneval, Esther Soo Hyun Kim, Jeffrey W Olin, Heather L Gornik, Michel Azizi, Pierre-François Plouin, Patrick T Ellinor, Iftikhar J Kullo, David J Milan, Santhi K Ganesh, Pierre Boutouyrie, Jason C Kovacic, Xavier Jeunemaitre, Nabila Bouatia-Naji, Soto Romuald Kiando, Nathan R Tucker, Luis-Jaime Castro-Vega, Alexander Katz, Valentina D'Escamard, Cyrielle Tréard, Daniel Fraher, Juliette Albuisson, Daniella Kadian-Dodov, Zi Ye, Erin Austin, Min-Lee Yang, Kristina Hunker, Cristina Barlassina, Daniele Cusi, Pilar Galan, Jean-Philippe Empana, Xavier Jouven, Anne-Paule Gimenez-Roqueplo, Patrick Bruneval, Esther Soo Hyun Kim, Jeffrey W Olin, Heather L Gornik, Michel Azizi, Pierre-François Plouin, Patrick T Ellinor, Iftikhar J Kullo, David J Milan, Santhi K Ganesh, Pierre Boutouyrie, Jason C Kovacic, Xavier Jeunemaitre, Nabila Bouatia-Naji

Abstract

Fibromuscular dysplasia (FMD) is a nonatherosclerotic vascular disease leading to stenosis, dissection and aneurysm affecting mainly the renal and cerebrovascular arteries. FMD is often an underdiagnosed cause of hypertension and stroke, has higher prevalence in females (~80%) but its pathophysiology is unclear. We analyzed ~26K common variants (MAF>0.05) generated by exome-chip arrays in 249 FMD patients and 689 controls. We replicated 13 loci (P<10-4) in 402 cases and 2,537 controls and confirmed an association between FMD and a variant in the phosphatase and actin regulator 1 gene (PHACTR1). Three additional case control cohorts including 512 cases and 669 replicated this result and overall reached the genomic level of significance (OR = 1.39, P = 7.4×10-10, 1,154 cases and 3,895 controls). The top variant, rs9349379, is intronic to PHACTR1, a risk locus for coronary artery disease, migraine, and cervical artery dissection. The analyses of geometrical parameters of carotids from ~2,500 healthy volunteers indicate higher intima media thickness (P = 1.97×10-4) and wall to lumen ratio (P = 0.002) in rs9349379-A carriers, suggesting indices of carotid hypertrophy previously described in carotids of FMD patients. Immunohistochemistry detected PHACTR1 in endothelium and smooth muscle cells of FMD and normal human carotids. The expression of PHACTR1 by genotypes in primary human fibroblasts showed higher expression in rs9349379-A carriers (N = 86, P = 0.003). Phactr1 knockdown in zebrafish resulted in dilated vessels indicating subtle impaired vascular development. We report the first susceptibility locus for FMD and provide evidence for a complex genetic pattern of inheritance and indices of shared pathophysiology between FMD and other cardiovascular and neurovascular diseases.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Association between rs9349379 and artery…
Fig 1. Association between rs9349379 and artery thickness in healthy controls.
Intima-media thickness and wall to lumen ratio are presented by genotype in all (A,D) women (B,E) and men (C,F) participants. We indicated p-values for the linear regression analyses under the additive model adjusted for age, sex and body surface area.
Fig 2. PHACTR1 mRNA expression and immunostaining.
Fig 2. PHACTR1 mRNA expression and immunostaining.
(A) PHACTR1 mRNA expression in human fibroblasts. PHACTR1 mRNA levels were determined by RT-qPCR in cultured fibroblasts from controls (N = 39) and FMD cases (N = 51). GAPDH expression was used as control for normalization and data are expressed as mean fold change of PHACTR1 relative to GAPDH. There is a non-significant trend toward overexpression of PHACTR1 in FMD cases compared to controls (P = 0.61, Mann-Whitney test) whereas significant differences are uncovered after stratification by genotypes (P = 0.003, Kruskal-Wallis test). (B) Immunostaining of normal and FMD internal carotid using anti-PHACTR1 antibody. PHACTR1 was detected in endothelium and smooth muscle cells in the media. Staining is mostly cytoplasmic with regular alignment in normal carotids and typical disorganized cellular structure in media of FMD carotid.
Fig 3. phactr1 modulation in zebrafish affects…
Fig 3. phactr1 modulation in zebrafish affects vascular dimensions and patterning.
Two-dimensional projections obtained from z-series confocal images in the trunk of control and phactr1 knockdown (KD) zebrafish embryos (two representative images per condition). Green represents the vascular endothelium as marked by EGFP. Greyscale represents the corresponding DIC bright field image of the fish trunk. DA: Dorsal aorta, SV: Segmental vessel, PCV: Posterior cardinal vein. Quantification of inner vascular diameter for the dorsal aorta (DA), posterior cardinal vein (PCV) and caudal artery (CA). (*) represents P<0.05.

References

    1. Olin JW, Sealove BA (2011) Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg 53: 826–836 e821. 10.1016/j.jvs.2010.10.066
    1. Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, et al. (2007) Fibromuscular dysplasia. Orphanet J Rare Dis 2: 28 10.1186/1750-1172-2-28
    1. Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, et al. (2012) The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation 125: 3182–3190. 10.1161/CIRCULATIONAHA.112.091223
    1. Cragg AH, Smith TP, Thompson BH, Maroney TP, Stanson AW, et al. (1989) Incidental fibromuscular dysplasia in potential renal donors: long-term clinical follow-up. Radiology 172: 145–147. 10.1148/radiology.172.1.2662248
    1. Hendricks NJ, Matsumoto AH, Angle JF, Baheti A, Sabri SS, et al. (2014) Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in CORAL trial participants versus a single institution population of renal donor candidates. Vasc Med 19: 363–367. 10.1177/1358863X14544715
    1. Persu A, Giavarini A, Touze E, Januszewicz A, Sapoval M, et al. (2014) European consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens 32: 1367–1378. 10.1097/HJH.0000000000000213
    1. Savard S, Steichen O, Azarine A, Azizi M, Jeunemaitre X, et al. (2012) Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics. Circulation 126: 3062–3069. 10.1161/CIRCULATIONAHA.112.117499
    1. Pannier-Moreau I, Grimbert P, Fiquet-Kempf B, Vuagnat A, Jeunemaitre X, et al. (1997) Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens 15: 1797–1801.
    1. Kiando SR, Barlassina C, Cusi D, Galan P, Lathrop M, et al. (2015) Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia. J Hypertens 33: 1802–1810. 10.1097/HJH.0000000000000625
    1. McKenzie GA, Oderich GS, Kawashima A, Misra S (2013) Renal artery fibromuscular dysplasia in 2,640 renal donor subjects: a CT angiography analysis. J Vasc Interv Radiol 24: 1477–1480. 10.1016/j.jvir.2013.06.006
    1. Perdu J, Gimenez-Roqueplo AP, Boutouyrie P, Beaujour S, Laloux B, et al. (2006) Alpha1-antitrypsin gene polymorphisms are not associated with renal arterial fibromuscular dysplasia. J Hypertens 24: 705–710. 10.1097/01.hjh.0000217853.97369.42
    1. Poloskey SL, Kim E, Sanghani R, Al-Quthami AH, Arscott P, et al. (2012) Low yield of genetic testing for known vascular connective tissue disorders in patients with fibromuscular dysplasia. Vasc Med 17: 371–378. 10.1177/1358863X12459650
    1. Boutouyrie P, Gimenez-Roqueplo AP, Fine E, Laloux B, Fiquet-Kempf B, et al. (2003) Evidence for carotid and radial artery wall subclinical lesions in renal fibromuscular dysplasia. J Hypertens 21: 2287–2295. 10.1097/01.hjh.0000098143.70956.c1
    1. Engelen L, Ferreira I, Stehouwer CD, Boutouyrie P, Laurent S, et al. (2013) Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors. Eur Heart J 34: 2368–2380. 10.1093/eurheartj/ehs380
    1. Coronary Artery Disease Genetics C (2011) A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 43: 339–344. 10.1038/ng.782
    1. Beaudoin M, Gupta RM, Won HH, Lo KS, Do R, et al. (2015) Myocardial Infarction-Associated SNP at 6p24 Interferes With MEF2 Binding and Associates With PHACTR1 Expression Levels in Human Coronary Arteries. Arterioscler Thromb Vasc Biol 35: 1472–1479. 10.1161/ATVBAHA.115.305534
    1. Freilinger T, Anttila V, de Vries B, Malik R, Kallela M, et al. (2012) Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet 44: 777–782. 10.1038/ng.2307
    1. Anttila V, Winsvold BS, Gormley P, Kurth T, Bettella F, et al. (2013) Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat Genet 45: 912–917. 10.1038/ng.2676
    1. Debette S, Kamatani Y, Metso TM, Kloss M, Chauhan G, et al. (2015) Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection. Nat Genet 47: 78–83. 10.1038/ng.3154
    1. Bejot Y, Aboa-Eboule C, Debette S, Pezzini A, Tatlisumak T, et al. (2014) Characteristics and outcomes of patients with multiple cervical artery dissection. Stroke 45: 37–41. 10.1161/STROKEAHA.113.001654
    1. Saw J, Aymong E, Sedlak T, Buller CE, Starovoytov A, et al. (2014) Spontaneous coronary artery dissection: association with predisposing arteriopathies and precipitating stressors and cardiovascular outcomes. Circ Cardiovasc Interv 7: 645–655. 10.1161/CIRCINTERVENTIONS.114.001760
    1. Prasad M, Tweet MS, Hayes SN, Leng S, Liang JJ, et al. (2015) Prevalence of extracoronary vascular abnormalities and fibromuscular dysplasia in patients with spontaneous coronary artery dissection. Am J Cardiol 115: 1672–1677. 10.1016/j.amjcard.2015.03.011
    1. Michelis KC, Olin JW, Kadian-Dodov D, d'Escamard V, Kovacic JC (2014) Coronary artery manifestations of fibromuscular dysplasia. J Am Coll Cardiol 64: 1033–1046. 10.1016/j.jacc.2014.07.014
    1. Turner AW, McPherson R (2015) PHACTR1: Functional Clues Linking a Genome-Wide Association Study Locus to Coronary Artery Disease. Arterioscler Thromb Vasc Biol 35: 1293–1295. 10.1161/ATVBAHA.115.305680
    1. Allain B, Jarray R, Borriello L, Leforban B, Dufour S, et al. (2012) Neuropilin-1 regulates a new VEGF-induced gene, Phactr-1, which controls tubulogenesis and modulates lamellipodial dynamics in human endothelial cells. Cell Signal 24: 214–223. 10.1016/j.cellsig.2011.09.003
    1. Jarray R, Allain B, Borriello L, Biard D, Loukaci A, et al. (2011) Depletion of the novel protein PHACTR-1 from human endothelial cells abolishes tube formation and induces cell death receptor apoptosis. Biochimie 93: 1668–1675. 10.1016/j.biochi.2011.07.010
    1. Jarray R, Pavoni S, Borriello L, Allain B, Lopez N, et al. (2015) Disruption of phactr-1 pathway triggers pro-inflammatory and pro-atherogenic factors: New insights in atherosclerosis development. Biochimie.
    1. Consortium CAD (2015) A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet 47: 1121–1130. 10.1038/ng.3396
    1. Reschen ME, Lin D, Chalisey A, Soilleux EJ, O'Callaghan CA (2016) Genetic and environmental risk factors for atherosclerosis regulate transcription of phosphatase and actin regulating gene PHACTR1. Atherosclerosis 250: 95–105. 10.1016/j.atherosclerosis.2016.04.025
    1. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, et al. (2004) The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164: 2335–2342. 10.1001/archinte.164.21.2335
    1. Empana JP, Bean K, Guibout C, Thomas F, Bingham A, et al. (2011) Paris Prospective Study III: a study of novel heart rate parameters, baroreflex sensitivity and risk of sudden death. Eur J Epidemiol 26: 887–892. 10.1007/s10654-011-9618-x
    1. Ye Z, Kalloo FS, Dalenberg AK, Kullo IJ (2013) An electronic medical record-linked biorepository to identify novel biomarkers for atherosclerotic cardiovascular disease. Glob Cardiol Sci Pract 2013: 82–90. 10.5339/gcsp.2013.10
    1. Tang WH, Hazen SL (2014) The contributory role of gut microbiota in cardiovascular disease. J Clin Invest 124: 4204–4211. 10.1172/JCI72331
    1. Proust C, Empana JP, Boutouyrie P, Alivon M, Challande P, et al. (2015) Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3. Circ Cardiovasc Genet 8: 628–636. 10.1161/CIRCGENETICS.114.000979
    1. Guo Y, He J, Zhao S, Wu H, Zhong X, et al. (2014) Illumina human exome genotyping array clustering and quality control. Nat Protoc 9: 2643–2662. 10.1038/nprot.2014.174
    1. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559–575. 10.1086/519795
    1. Patterson N, Price AL, Reich D (2006) Population structure and eigenanalysis. PLoS Genet 2: e190 10.1371/journal.pgen.0020190
    1. Meinders JM, Brands PJ, Willigers JM, Kornet L, Hoeks AP (2001) Assessment of the spatial homogeneity of artery dimension parameters with high frame rate 2-D B-mode. Ultrasound Med Biol 27: 785–794.
    1. Van Bortel LM, Balkestein EJ, van der Heijden-Spek JJ, Vanmolkot FH, Staessen JA, et al. (2001) Non-invasive assessment of local arterial pulse pressure: comparison of applanation tonometry and echo-tracking. J Hypertens 19: 1037–1044.
    1. Willer CJ, Li Y, Abecasis GR (2010) METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26: 2190–2191. 10.1093/bioinformatics/btq340
    1. Lee S, Emond MJ, Bamshad MJ, Barnes KC, Rieder MJ, et al. (2012) Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet 91: 224–237. 10.1016/j.ajhg.2012.06.007
    1. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611–622. 10.1373/clinchem.2008.112797
    1. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101–1108.
    1. Dina C, Bouatia-Naji N, Tucker N, Delling FN, Toomer K, et al. (2015) Genetic association analyses highlight biological pathways underlying mitral valve prolapse. Nat Genet 47: 1206–1211. 10.1038/ng.3383

Source: PubMed

3
Abonnere